{
    "root": "737a438a-a4f6-4f8c-a6b1-f1e86f2e39db",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Vigabatrin",
    "value": "20221228",
    "ingredients": [
        {
            "name": "VIGABATRIN",
            "code": "GR120KRT6K"
        },
        {
            "name": "HYPROMELLOSES",
            "code": "3NXW29V3WO"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A"
        },
        {
            "name": "POVIDONE",
            "code": "FZ989GH94E"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2"
        }
    ],
    "indications": "vigabatrin tablets indicated treatment : refractory complex partial seizures adjunctive therapy patients 2 years age older responded inadequately several alternative treatments ; vigabatrin tablets indicated first line agent . ( 1.1 ) infantile spasms - monotherapy infants 1 month 2 years age potential benefits outweigh potential risk vision loss . ( 1.2 )",
    "contraindications": "refractory complex partial seizures adults ( 17 years age older ) : initiate 1,000 mg/day ( 500 mg twice daily ) ; increase total daily dose weekly 500 mg/day increments , recommended dose 3,000 mg/day . ( 1,500 mg twice daily ) ( 2.2 ) pediatric ( 2 16 years age ) : recommended based body weight administered two divided doses . ( 2.2 ) may increased weekly intervals , depending response . ( 2.2 ) dose patients weighing 60 kg according adult recommendations . ( 2.2 ) infantile spasms initiate daily dose 50 mg/kg ( 25 mg/kg twice daily ) ; increase total daily dose every 3 days , increments 25 mg/kg/day 50 mg/kg/day , maximum daily dose 150 mg/kg ( 75 mg/kg twice daily ) . ( 2.3 ) renal impairment : dose adjustment recommended . ( 2.4 , 8.5 , 8.6 )",
    "warningsAndPrecautions": null,
    "adverseReactions": "none .",
    "indications_original": "Vigabatrin tablets are indicated for the treatment of: Refractory Complex Partial Seizures as adjunctive therapy in patients 2 years of age and older who have responded inadequately to several alternative treatments; vigabatrin tablets are not indicated as a first line agent.\u00a0( 1.1 ) Infantile Spasms - monotherapy in infants 1 month to 2 years of age for whom the potential benefits outweigh the potential risk of vision loss.\u00a0( 1.2 )",
    "contraindications_original": "Refractory Complex Partial Seizures Adults (17 years of age and older): Initiate at 1,000 mg/day (500 mg twice daily); increase total daily dose weekly in 500 mg/day increments, to the recommended dose of 3,000 mg/day. (1,500 mg twice daily)\u00a0( 2.2 ) Pediatric (2 to 16 years of age): The recommended dosage is based on body weight and administered as two divided doses.\u00a0( 2.2 ) The dosage may be increased in weekly intervals, depending on response.\u00a0( 2.2 ) Dose patients weighing more than 60 kg according to adult recommendations.\u00a0( 2.2 ) Infantile Spasms Initiate at a daily dose of 50 mg/kg (25 mg/kg twice daily); increase total daily dose every 3 days, in increments of 25 mg/kg/day to 50 mg/kg/day, up to a maximum daily dose of 150 mg/kg (75 mg/kg twice daily).\u00a0( 2.3 ) Renal Impairment: Dose adjustment recommended.\u00a0( 2.4 , 8.5 , 8.6 )",
    "adverseReactions_original": "None."
}